Integra Lifesciences (IART) has acquired Johnson & Johnson's (JNJ) neurosurgery medical device unit for $1.045 billion. Integra hopes this deal will grow its revenue to $2 billion sooner than expected. Stocks are pretty stable this a.m. in response. The deal is Integra's second this year.
It acquired a dermatology company in January. Johnson & Johnson is looking to divest its diabetes care assets still.